|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | In vitro chemosensitivity testing and mechanisms of drug resistance 显示文摘 | Krishnansu Tewari Alberto Manetta | 1999 | Curr Oncol Rep1999，1，： | 1 |
| 2 | Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer显示文摘 | Krishnansu Tewari Ramez N Eskander | 2013 | Clinical Pharmacology: Advances and Applications (Supplement )2013，，1： | 1 |
| 3 | Multimodality therapy for locally advanced cervical carcinoma:State of the art and future directions显示文摘 | Bradley J Monk Krishnansu S | | 0，，10： | 1 |
| 4 | cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer显示文摘 | Ramez N eskander Krishnansu S Tewariepithelial | 2013 | Clin Pharmacol Advances Applications2013，5，1： | 1 |
| 5 | Relapse of Acute Lymphoblastic Leukemia in Pregnancy Survival Following Chemoirradiation and Autologous显示文摘 | Krishnansu T Fabio C | 1999 | Int J Gynecol Oncol1999，74，： | 1 |
| 6 | Intrahepatic cholangiocarcinoma masquerading as the HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count) in pregnancy: Case report显示文摘 | Keith D. Balderston Krishnansu Tewari Faramarz Azizi Jerry K. Yu | 1998 | American Journal of Obstetrics and Gynecology1998，，3： | 1 |
| 7 | Improved sur- vival with hevacizumab in advanced cervical cancer显示文摘 | Krishnansu S Tewari MD Michael W | 2014 | N Engl J Med2014，370，： | 1 |
| 8 | Multimodality therapy for locally advanced cervical carcinoma:State of the art and future directions显示文摘 | Bradley J Monk Krishnansu S | 2007 | J Clin Oncol2007，25，10： | 1 |
| 9 | Use of stereotactic radiosurgery in the treatment of gynecologic malignancies:A review显示文摘Recent retrospective studies have reported the use ofstereotactic radiosurgery(SRS) in the treatment of gy-necologic cancers. SRS uses real-time imaging and highdose radiation beams attached to precise robotic armsto target malignant lesions while sparing normal tissue.The purpose of this review is to examine the indicationsfor SRS in gynecologic oncology, review the currentliterature regarding the use of SRS in gynecologic can-cers, and identify future directions for research in thisarea. Literature on stereotactic radiosurgery was re-viewed using the PubMed search engine. Articles writ-ten in English from 1993-2013 were reviewed, and 20 case series and clinical trials were included. The safetyand efficacy SRS has been demonstrated in all gyne-cologic disease sites including cervical, endometrial,vulvar, vaginal, and ovarian cancers. Indications for itsuse include non-central pelvic recurrences in previouslyirradiated patients, complex or non-resectable diseaserecurrence, and solitary brain metastases. Toxicitiesare usually mild, though grade 3-4 toxicities have been reported. SRS is a promising second line treatment modality for patients with primary or recurrent disease who cannot undergo standard surgical or radiation therapy. Further research is required to determine optimal dosing and fractionation schedules, delineate appropriate patient populations, and assess longterm morbidity and survival. | Beverly Long Ramez N Eskander Krishnansu S Tewari | 2014 | World Journal of Radiology2014，6，6： | 0 |
| 10 | Sentinel lymph node mapping of a breast cancer of the vulva: Case report and literature review显示文摘Ectopic breast tissue is rare and typically presents as an axillary mass. Previous reports have identified ectopic breast tissue in the vulva, but malignancy is exceedingly uncommon. We present a 62 years old with locally advanced breast carcinoma arising in the vulva demonstrates the utilization of sentinel lymph node mapping to identify metastatic lymph nodes previously unable to be identified via traditional surgical exploration.Our case supports the principles of adjuvant therapy for breast cancer to be applied to ectopic breast cancer arising in the vulva. A literature review highlights common key points in similar cases to guide management. | James Cripe Ramez Eskander Krishnansu Tewari | 2015 | World Journal of Clinical Oncology2015，6，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员